“Low incidence of anti-pf4/heparin antibodies in patients with acute myelogenous leukemia”., Mediterr J Hematol Infect Dis, vol. 16, no. 1, p. e2024057, Jun. 2024, doi: 10.4084/MJHID.2024.057.